Omalizumab in chronic spontaneous urticaria: a brazilian real-life experience (2016)
Source: International Archives of Allergy and Immunology. Unidade: FMRP
Subjects: ANTI-HISTAMÍNICOS H1, DOENÇA CRÔNICA, IMUNOGLOBULINA E, URTICÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENSINA, Luis Felipe et al. Omalizumab in chronic spontaneous urticaria: a brazilian real-life experience. International Archives of Allergy and Immunology, v. 169, n. 2, p. 121-124, 2016Tradução . . Disponível em: https://doi.org/10.1159/000444985. Acesso em: 16 out. 2024.APA
Ensina, L. F., Valle, S. O. R., Juliani, A. P., Galeane, M., Santos, R. V. dos, Arruda, L. K. de P., et al. (2016). Omalizumab in chronic spontaneous urticaria: a brazilian real-life experience. International Archives of Allergy and Immunology, 169( 2), 121-124. doi:10.1159/000444985NLM
Ensina LF, Valle SOR, Juliani AP, Galeane M, Santos RV dos, Arruda LK de P, Melo JML, Souza PK, Serpa FS, Andrade DM de, França AT, Campos RA, Camelo-Nunes I, Solé D. Omalizumab in chronic spontaneous urticaria: a brazilian real-life experience [Internet]. International Archives of Allergy and Immunology. 2016 ; 169( 2): 121-124.[citado 2024 out. 16 ] Available from: https://doi.org/10.1159/000444985Vancouver
Ensina LF, Valle SOR, Juliani AP, Galeane M, Santos RV dos, Arruda LK de P, Melo JML, Souza PK, Serpa FS, Andrade DM de, França AT, Campos RA, Camelo-Nunes I, Solé D. Omalizumab in chronic spontaneous urticaria: a brazilian real-life experience [Internet]. International Archives of Allergy and Immunology. 2016 ; 169( 2): 121-124.[citado 2024 out. 16 ] Available from: https://doi.org/10.1159/000444985